Unbiased Analysis of Today's Healthcare Issues
The Innovation and Value Initiative today announced that it is in the process of releasing a new model and value tool to evaluate treatments for for EGFR-positive non-small cell lung cancer (NSCLC). More details on the model (named the IVI-NSCLC model) are available here, which includes a study protocol and model timeline. Oncology is an…
While many advancements have been made thus far in the progression toward value-based health care, there are persistent challenges in the measurement of value. In order to deliver value-based care, health care decision makers, eg, insurers and health system administrators, need value data at their fingertips—data that are relevant to their own context and reflect…
Today I participated in a fantastic panel presentation at the 2018 Academy of Managed Care & Specialty Pharmacy Conference in Boston. Moderated by Jonathan Collar of Cigna-Health Spring, the session discussed “New Tools for Measuring Treatment Value in Rheumatoid Arthritis“. My co-presenters were Jeroen Jansen from the Innovation and Value Initiative and Dr. Jeff Curtis, a…
The Innovation and Value Initiative (IVI) – a collaboration of academics, patient advocacy organizations, payers, life sciences companies, providers, delivery systems, and other organizations dedicated to finding scientifically credible approaches to measuring value in health care – today released a report examining imbalances in cost-effectiveness analyses (CEAs) across pharmaceuticals, medical/surgical treatments, and mixed procedures. The report, Expanding Cost-Effectiveness…
This is the title of an interesting commentary in Modern Healthcare by my colleague Mark Linthicum. An excerpt is below. In healthcare, different stakeholders have vastly different perceptions of value, with important implications for decisionmaking. An employer paying for healthcare may want to find solutions that decrease employee absences and prevent lengthy hospitalizations. A health…
That is the title of a recent article in Managed Healthcare Executive on the Innovation and Value Initiative’s new Open-Source Value Project. The magazine interviewed Mark Linthicum, IVI’s Director of Scientific Communication. An excerpt is below: Linthicum: Many healthcare stakeholders are now being asked to make decisions based on value, but few are also given…
On November 8th, the Innovation and Value Initiative (IVI) launched a new effort to help redefine the way we measure value in health care: the Open-Source Value Project (OSVP). A first-of-its-kind effort that engages all health care stakeholders in an open process to advance the way we measure value in health care treatments and services,…
The Innovation and Value Initiative (IVI)–where I serve as the Director of Research–today released its first Open-Source Value Project in rheumatoid arthritis. I have pasted the press release below. Go check it out! Press release: The Innovation and Value Initiative (IVI) – a collaboration of academics, patient advocacy organizations, payers, life sciences companies, providers, delivery systems, and other organizations dedicated to finding scientifically…
As reported in a Academy of Managed Care & Specialty Pharmacy newsletter, titled “Mathematical Model Aims to Improve Cost-Effectiveness of Rheumatology Treatment“, the Innovation and Value Initiative’s is highlighted from the American College of Rheumatology conference. Here is an excerpt: Biological therapies for moderate to severe rheumatoid arthritis have significantly improved treatment and prognosis. However,…
Morning Consult has an interesting piece from Mark Linthicum, the Director of Scientific Communication at the Innovation and Value Initiative (IVI) titled “Why Understanding Value Is Central to True Health Care Reform“. In the piece he argues: The true problem is that dollars are poured into a system without any clear understanding of how worthwhile…